Company: RGNX
Filing Date: 2025-04-08
Form Type: DEF 14A
Source: 0000950170-25-052069
Chunk: 54

Company: REGENXBIO Inc.
Filing Date: 2025-04-08
Form: DEF 14A
Chunk 54
---
 through July 1, 2024, on which date he was appointed President and CEO. (5) Mitchell Chan joined the Company as EVP, Chief Financial Officer on September 16, 2024. Information reported for Mr. Chan reflects his compensation for the period from September 16, 2024 through December 31, 2024. (6) All other compensation reported for Dr. Danos includes employer matching contributions to our 401(k) plan as well as corporate housing costs and related tax gross-up. All other compensation reported for Dr. Danos for 2024 consists of (i) employer matching contributions to our 401(k) plan of $19,838 and (ii) corporate housing costs of $15,015 and related tax gross-up of $6,597. Corporate housing benefits to our NEOs were discontinued during 2024. (7) Kenneth T. Mills' last day of employment as President and CEO was July 1, 2024, on which date he was appointed Chairman of the Board of Directors. Information reported for 2024 for Mr. Mills reflects his compensation as President and CEO through July 1, 2024, and as non-executive Chairman of the Board of Directors for the period from July 1, 2024 through December 31, 2024. In accordance with the Mills Consulting and Employment Separation Agreement, Mr. Mills received his full target cash incentive award for 2024 as well as other termination benefits which are reported within all other compensation for 2024. All other compensation reported for Mr. Mills for 2024 consists of (i) employer matching contributions to our 401(k) plan of $11,250, (ii) total expected COBRA premiums of $15,015, (iii) legal expense reimbursement of $25,000 and (iv) non-employee director compensation of $40,000 for his service as a director and Chairman of the Board of Directors following his resignation as CEO. For additional information, please refer to “Employment Agreements and Potential Payments upon Termination or Change in Control” on page 41 . (8) Vit Vasista's last day of employment as EVP and Chief Financial Officer was September 16, 2024, and on such date entered into a Consulting Agreement (the “Vasista Consulting Agreement”), for services that he provided as an advisor to the Company to assist the Chief Executive Officer until January 3, 2025. In accordance with the Vasista Separ